Compare Hormel Foods Corp (HRL) vs Intuitive Surgical, Inc. (ISRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hormel Foods Corp vs Intuitive Surgical, Inc. — how do they compare? Hormel Foods Corp trades at $19.19 (market cap $10.69B), while Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B). The key difference: Intuitive Surgical, Inc. is far larger — about 13.7× Hormel Foods Corp's market cap, and Hormel Foods Corp pays a 6.02% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hormel Foods Corp for 99 Days and Intuitive Surgical, Inc. for 84 Days on average.
| HRL | ISRG | |
|---|---|---|
Market Cap | $10.69B | $146.76B |
Volume | 10,041,387 | 2,529,814 |
Sector | Consumer Staples | Health |
52-Week High | $26.50 | $592.85 |
52-Week Low | $19.19 | $332.02 |
Typical Hold Time | 99 Days | 84 Days |
Enterprise Value | $12.67B | $141.54B |
Dividend Yield | 6.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hormel Foods (HRL) trades at $19.42, down 0.66% with a bearish technical signal. The company shows mixed fundamentals with a P/E of 31.32 and net margin of 2.82%, though it has beaten EPS estimates in recent quarters. Recent news highlights the $1.06B Brakebush acquisition to expand foodservice presence, while maintaining its 60-year dividend king status with a quarterly payout of $0.2925.
The outlook is cautious with analyst consensus at Buy 20%/Hold 57%/Sell 23% and a $24.25 price target suggesting 25% upside. Key risks include declining profit margins, high payout ratio concerns, and integration challenges from the Brakebush acquisition. The stock offers dividend stability but faces growth headwinds in a competitive food sector.
Intuitive Surgical (ISRG) trades at $415.41, up 0.21% with a bullish technical outlook. The stock shows strong fundamentals with 2025 revenue of $10.06B and net income of $2.86B, maintaining consistent earnings beats. Valuation metrics remain elevated with a P/E of 47.64 and P/S of 13.54, reflecting premium pricing for the robotic surgery leader. Recent news highlights international expansion in India and Japan to offset China weakness, while da Vinci 5 upgrades and ASC market penetration drive growth.
ISRG presents a compelling growth story with dominant market position and expanding global footprint, though premium valuation requires sustained execution. Key risks include procedure growth moderation and competitive pressures. Analyst consensus remains strongly bullish with $480.78 price target representing 16% upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hormel Foods Corp
Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.
Read more on HRL →About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →
